Name : BBS7 Antibody, ALEXA FLUOR 647
Supplier : BIOSS PRIMARY CONJUGATED ANTIBODIES
Price :332
SKU : GEN7588195067
| Long name | ALEXA FLUOR 647 Conjugated, BBS7 Polyclonal Antibody |
| Also known as | Anti-BBS7 PAb ALEXA FLUOR 647 |
| Category | Conjugated Primary Antibodies |
| Conjugated with | 647, ALEXA FLUOR® |
| Host Organism | Rabbit (Oryctolagus cuniculus) |
| Target Antigen | BBS7 |
| Specificity | This is a highly specific antibody against BBS7 |
| Modification | Unmodified |
| Modification Site | None |
| Clonality | Polyclonal |
| Clone | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human BBS7 |
| Tested applications | IF(IHC-P) |
| Recommended dilutions | IF(IHC-P)(1:50-200) |
| Crossreactivity | Mouse, Rat, Human |
| Cross-reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the antigen | BBS is a heterogeneous disorder mapping to eight genetic loci and encoding eight proteins, BBS patients also have an increased risk of developing diabetes, BBS1-BBS8, BBS2 contains two overlapping genes: BBS2L1 and BBS2L2, BBS7 contains 672 amino acids and is expressed at low to moderate levels in most human tissues, BBSL1 was re-named BBS7, Five BBS proteins encode basal body or cilia proteins, and congenital heart defects, and developmental delay, hypertension, hypogenitalism, photoreceptor degeneration, polydactyly, renal abnormalities, suggesting that BBS is a ciliary dysfunction disorder, whereas BBS2L2 independently funcitons as BBS1, Bardet-Biedl syndrome (BBS) is a pleiotropic genetic disorder characterized by obesity |
| Purification | Purified by Protein A |
| Storage conditions | 50% glycerol and 0, Keep refrigerated at 2 to 8 degrees Celcius for up to one year, 09% sodium azide, Store this antibody in aqueous buffered solution containing 1% BSA |
| Excitation emission | 650nm/665nm |
| Synonyms | FLJ10715 BBS2L1 |
| Properties | ALEXA FLUOR made this Alexa Fluor 633 conjugate that can be used in multi-color flow cytometry with instruments equipped with a second red laser or red diode, ALEXA FLUOR they should be stored frozen at - 24°, Alexa Fluor 633 is a practical alternative to APC as well as Cy5, Bioss Primary Conjugated Antibodies, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies, It is detected in the FL4 detector of the core's upgraded 2-laser FACScans, Like other Alexa Fluor dyes, exhibits uncommon photo stability, making it an ideal choice for fluorescent microscopy, the BBS7 Antibody, C, C for long term storage and for short term at + 5°, For facs or microscopy Alexa 1 conjugate |
| Conjugation | ALEXA FLUOR 647, Alexa Fluor |
| Gene target | BBS7 |
| Short name | BBS7 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Label | ALEXA FLUOR 647 |
| Alternative name | ALEXA FLUOR 647, Bardet-Biedl syndrome 7 (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | BBS7 and IDBG-36452 and ENSG00000138686 and 55212, BBS7 and IDBG-639728 and ENSBTAG00000004945 and 100138953, Bbs7 and IDBG-138825 and ENSMUSG00000037325 and 71492, nuclei, protein binding, this GO :0001103 and RNA polymerase II repressing transcription factor binding and molecular function this GO :0001654 and eye development and biological process this GO :0001947 and heart looping and biological process this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005813 and centrosome and cellular component this GO :0005930 and axoneme and cellular component this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0007224 and smoothened signaling pathway and biological process this GO :0007368 and determination of left/right symmetry and biological process this GO :0007420 and brain development and biological process this GO :0007507 and heart development and biological process this GO :0007601 and visual perception and biological process this GO :0008104 and protein localization and biological process this GO :0015031 and protein transport and biological process this GO :0032402 and melanosome transport and biological process this GO :0032436 and positive regulation of proteasomal ubiquitin-dependent protein catabolic process and biological process this GO :0034464 and BBSome and cellular component this GO :0035058 and nonmotile primary cilium assembly and biological process this GO :0036064 and ciliary basal body and cellular component this GO :0045444 and fat cell differentiation and biological process this GO :0048546 and digestive tract morphogenesis and biological process this GO :0051877 and pigment granule aggregation in cell center and biological process this GO :0060021 and palate development and biological process this GO :0060170 and ciliary membrane and cellular component this GO :0060173 and limb development and biological process this GO :0060271 and cilium morphogenesis and biological process, this GO :0001103: RNA polymerase II repressing transcription factor binding, this GO :0001103: RNA polymerase II repressing transcription factor binding and also this GO :0005515: protein binding, this GO :0005515: protein binding, Bardet-Biedl syndrome 7 |
| Identity | 18758 |
| Gene | BBS7 |
| Long gene name | Bardet-Biedl syndrome 7 |
| Locus | 4q27 |
| Discovery year | 2003-02-05 |
| GenBank acession | AF521644 |
| Entrez gene record | 55212 |
| Classification | Bardet-Biedl syndrome associated BBSome |
| Havana BLAST/BLAT | OTTHUMG00000133076 |
| Locus Specific Databases | Mutations of the Bardet-Biedl Syndrome Type 7 Gene (BBS2L1) |